Page last updated: 2024-10-17

aminocaproic acid and Bradyarrhythmia

aminocaproic acid has been researched along with Bradyarrhythmia in 1 studies

Aminocaproic Acid: An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties.
6-aminohexanoic acid : An epsilon-amino acid comprising hexanoic acid carrying an amino substituent at position C-6. Used to control postoperative bleeding, and to treat overdose effects of the thrombolytic agents streptokinase and tissue plasminogen activator.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jy, W1
Gagliano-DeCesare, T1
Kett, DH1
Horstman, LL1
Jimenez, JJ1
Ruiz-Dayao, Z1
Santos, ES1
Ahn, YS1

Other Studies

1 other study available for aminocaproic acid and Bradyarrhythmia

ArticleYear
Life-threatening bleeding from refractory acquired FVIII inhibitor successfully treated with rituximab.
    Acta haematologica, 2003, Volume: 109, Issue:4

    Topics: Aged; Aged, 80 and over; Aminocaproic Acid; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-D

2003